|

Moderna Inc (MRNA) Stock Forecast: Surge gives investors a shot in the arm as it prepares to deliver 1 billion doses in 2021

  • NASDAQ:MRNA gains 4.56% as broader markets rally on Biden’s stimulus optimism.

  • The Swiss government becomes the latest country to order the COVID-19 vaccine from Moderna.

  • Moderna announces three new vaccines for the seasonal flu, Nipah virus, and HIV.

NASDAQ:MRNA is riding high after CEO Stephane Bancel announced that the company is slated to distribute over 1 billion doses of its COVID-19 vaccine candidate by the end of 2021. Investors embraced the news as shares of Moderna rose by 4.56% on Thursday to close the trading session at $129.72 as it continues to climb back from the late year beat down it took as new strains of the novel coronavirus started to emerge. The stock price dipped close to $100 on December 31st, but has rebounded nicely in the first couple trading weeks of 2021. 

Switzerland announced it is the latest Moderna client as the European nation ordered 7.5 million doses of mRNA-1273, as the country battles through a surge of the virus at the end of 2020. In other Swiss news, drugmaker Lonza is awaiting approval to begin making active ingredients for mRNA-1273 which could boost Moderna’s supply chain in Europe, which remains one of the hardest hit regions in the world. 

MRNA stock price

Moderna Inc (MRNA) stock chart

Moderna also announced that it has three new non COVID-19 vaccines coming down their pipelines for HIV, the seasonal flu, and Nipah virus, which should be ready to enter Phase 1 of the clinical trials at some point in 2021. The vaccines are said to include components that will help fight against SARS-CoV-2 as well, which is the virus strain that results in COVID-19. Perhaps word of Moderna’s success is spreading as a recent poll in the United States shows growing support in receiving the vaccine after initially it was met with skepticism by Americans. 

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

More from Stocks Reporter
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD moves sideways below 1.1800 on Christmas Eve

EUR/USD struggles to find direction and trades in a narrow channel below 1.1800 after posting gains for two consecutive days. Bond and stock markets in the US will open at the usual time and close early on Christmas Eve, allowing the trading action to remain subdued. 

GBP/USD keeps range around 1.3500 amid quiet markets

GBP/USD keeps its range trade intact at around 1.3500 on Wednesday. The Pound Sterling holds the upper hand over the US Dollar amid pre-Christmas light trading as traders move to the sidelines heading into the holiday season. 

Gold retreats from record highs, trades below $4,500

Gold retreats after setting a new record-high above $4,520 earlier in the day and trades in a tight range below $4,500 as trading volumes thin out ahead of the Christmas break. The US Dollar selling bias remains unabated on the back of dovish Fed expectations, which continues to act as a tailwind for the bullion amid persistent geopolitical risks.

Bitcoin slips below $87,000 as ETF outflows intensify, whale participation declines

Bitcoin price continues to trade around $86,770 on Wednesday, after failing to break above the $90,000 resistance. US-listed spot ETFs record an outflow of $188.64 million on Tuesday, marking the fourth consecutive day of withdrawals.

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Avalanche struggles near $12 as Grayscale files updated form for ETF

Avalanche trades close to $12 by press time on Wednesday, extending the nearly 2% drop from the previous day. Grayscale filed an updated form to convert its Avalanche-focused Trust into an ETF with the US Securities and Exchange Commission.